{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:09:17Z","timestamp":1793653757493,"version":"4.5.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clinthera.2013.09.004","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T04:30:11Z","timestamp":1381897811000},"page":"1490-1500.e7","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Rhynn J.","family":"Malloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir O.","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.09.004_bib1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.09.004_bib2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib3","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.0000085829.60324.DE","article-title":"Thirty-year projections for deaths from ischemic stroke in the United States","volume":"34","author":"Elkins","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1212\/01.WNL.0000063309.41867.0F","article-title":"Prevalence and knowledge of transient ischemic attack among US adults","volume":"60","author":"Johnston","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2013.09.004_bib5","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.09.004_bib6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/01.WNL.0000129482.70315.2F","article-title":"The high risk of stroke immediately after transient ischemic attack: a population-based study","volume":"62","author":"Hill","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2013.09.004_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","article-title":"Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services","volume":"328","author":"Coull","year":"2004","journal-title":"BMJ"},{"issue":"2 Suppl","key":"10.1016\/j.clinthera.2013.09.004_bib8","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.09.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clinthera.2013.09.004_bib10","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.clinthera.2013.09.004_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2288-10-54","article-title":"Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial","volume":"10","author":"Woods","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinthera.2013.09.004_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.dss.2012.10.005","article-title":"ADDIS: a decision support system for evidence-based medicine","volume":"55","author":"van Valkenhoef","year":"2013","journal-title":"Decis Support Syst"},{"key":"10.1016\/j.clinthera.2013.09.004_bib14","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2013.09.004_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.clinthera.2013.09.004_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-148-7-200804010-00011","article-title":"Exploring the geometry of treatment networks","volume":"148","author":"Salanti","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib19","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.09.004_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","article-title":"Persantine Aspirin Trial in cerebral ischemia, part II: endpoint results","volume":"16","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","article-title":"Controlled trial of aspirin in cerebral ischemia","volume":"8","author":"Fields","year":"1977","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","article-title":"Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study","volume":"62","author":"Culebras","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2013.09.004_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.14.1.15","article-title":"Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danish cooperative study","volume":"14","author":"Sorensen","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.19.10.1211","article-title":"Danish very-low-dose aspirin after carotid endarterectomy trial","volume":"19","author":"Boysen","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib27","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Group","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib28","first-page":"1122","article-title":"ESPS Group","volume":"21","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinthera.2013.09.004_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1747-4949.2010.00535.x","article-title":"Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial","volume":"6","author":"Hankey","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","article-title":"Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study","volume":"7","author":"Huang","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2013.09.004_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","article-title":"Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial","volume":"377","author":"Bousser","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","volume":"23","author":"Diener","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.clinthera.2013.09.004_bib36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib37","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/STROKEAHA.107.505131","article-title":"Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): a randomized, double-blind, aspirin-controlled trial","volume":"39","author":"Shinohara","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.09.004_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1474-4422(10)70198-8","article-title":"Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial","volume":"9","author":"Shinohara","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2013.09.004_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.STR.18.2.325","volume":"18","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2169\/internalmedicine.42.793","article-title":"Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke","volume":"42","author":"Ito","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.004_bib44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/eurheartj\/ehn106","article-title":"Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke","volume":"29","author":"Thijs","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2013.09.004_bib45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/STROKEAHA.107.496281","article-title":"Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis","volume":"39","author":"Verro","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib46","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/STROKEAHA.111.637686","article-title":"Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Geeganage","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.09.004_bib47","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/CIRCULATIONAHA.106.675991","article-title":"Variable platelet response to aspirin and clopidogrel in atherothrombotic disease","volume":"115","author":"Maree","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.09.004_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrcardio.2009.10","article-title":"Antiplatelet drug \u201cresistance,\u201d part 1: mechanisms and clinical measurements","volume":"6","author":"Sweeny","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clinthera.2013.09.004_bib49","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.09.004_bib50","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300951X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300951X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T04:53:28Z","timestamp":1539320008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181300951X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S014929181300951X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.09.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}